| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9f7f665a5b37078501535a1089f71a78 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65846
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-655
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-724 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-724
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6584
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-40 |
| filingDate |
2003-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9931cf40a3beab36483de7ce48bd098
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56efb8776d3a6d41e0f5f61abf976e2e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a9f7eb528d677c0087cab890d5a535f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4048b2bd146ca3deec851e39926158cc |
| publicationDate |
2009-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EA-012368-B1 |
| titleOfInvention |
COMPOSITIONS OF IFOSFAMIDE FOR PARENTERAL INTRODUCTION AND METHOD OF THEIR RECEIVING |
| abstract |
The present invention provides aqueous ifosfamide compositions and a process for the preparation thereof, wherein the compositions have reduced toxicity compared to the concomitant use of a mesna uroprotective agent. Aqueous ifosfamide compositions can be prepared at concentrations up to 1100 mg / ml. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9579346-B2 |
| priorityDate |
2002-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |